Cargando…

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems

Parkinson’s disease (PD) is a devastating neurodegenerative disease characterized by progressive destruction of dopaminergic tissue in the central nervous system (CNS). To date, there is no cure for the disease, with current pharmacological treatments aimed at controlling the symptoms. Therefore, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paccione, Nicola, Rahmani, Mahdieh, Barcia, Emilia, Negro, Sofía
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866990/ https://www.ncbi.nlm.nih.gov/pubmed/36678642 http://dx.doi.org/10.3390/pharmaceutics15010013

Ejemplares similares

Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease
por: Casanova, Yaquelyn, et al.
Publicado: (2022)

Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs
por: Silva, Sara, et al.
Publicado: (2021)

Antipsychotics dosage and antiparkinsonian prescriptions
por: Acquaviva, Eric, et al.
Publicado: (2007)

A STUDY OF PROPHYLACTIC VALUE OF ANTIPARKINSONIAN DRUG
por: Behere, P.B., et al.
Publicado: (1983)

1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents
por: Ortíz de Zárate, Ana, et al.
Publicado: (2021)

Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis
por: Nimmons, Danielle, et al.
Publicado: (2021)

Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder
por: Massari, Caio M., et al.
Publicado: (2017)

Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011
por: Pitcher, T. L., et al.
Publicado: (2014)

Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication
por: Chung, Jae Woo, et al.
Publicado: (2017)

Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets
por: Michel, Anne, et al.
Publicado: (2017)

The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate
por: Lieu, Christopher A., et al.
Publicado: (2012)

Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson’s disease
por: Taguchi, Soutarou, et al.
Publicado: (2021)

Antiparkinsonian medication masks motor signal progression in de novo patients()
por: Brzezicki, Maksymilian A., et al.
Publicado: (2023)

LUHMES Cells: Phenotype Refinement and Development of an MPP(+)-Based Test System for Screening Antiparkinsonian Drugs
por: Beliakov, Sergei V., et al.
Publicado: (2023)

Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling
por: Bonito-Oliva, Alessandra, et al.
Publicado: (2011)

Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
por: Miguelez, Cristina, et al.
Publicado: (2017)

Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson’s Disease
por: SAMURA, Kazuhiro, et al.
Publicado: (2019)

Time until modification of antiparkinsonian therapy in a group of patients from Colombia
por: Valencia-Vásquez, Aníbal, et al.
Publicado: (2023)

Emerging Nano/Micro-Structured Degradable Polymeric Meshes for Pelvic Floor Reconstruction
por: Paul, Kallyanashis, et al.
Publicado: (2020)

Coumarin analogue 3-methyl-7H-furo[3,2-g]chromen-7-one as a possible antiparkinsonian agent
por: Olaya, María del Pilar, et al.
Publicado: (2019)

A New Stereoselective Approach to the Substitution of Allyl Hydroxy Group in para-Mentha-1,2-diol in the Search for New Antiparkinsonian Agents
por: Podturkina, Alexandra V., et al.
Publicado: (2023)

Rapid preparation process of antiparkinsonian drug Mucuna pruriens silver nanoparticle by bioreduction and their characterization
por: Arulkumar, Subramanian, et al.
Publicado: (2010)

Macro, Micro, and Nano-Inspired Bioactive Polymeric Biomaterials in Therapeutic, and Regenerative Orofacial Applications
por: Atia, Gamal A, et al.
Publicado: (2023)

c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism
por: Zhou, Yu, et al.
Publicado: (2018)

Characterization of steel lined with multilayer micro/nano-polymeric composites
por: Megahed, M., et al.
Publicado: (2022)

Motor Improvement-Related Regional Cerebral Blood Flow Changes in Parkinson's Disease in Response to Antiparkinsonian Drugs
por: Taguchi, Soutarou, et al.
Publicado: (2019)

Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis
por: Marcianes, Patricia, et al.
Publicado: (2017)

The 5-HT(2A) Receptor Antagonist M100907 Produces Antiparkinsonian Effects and Decreases Striatal Glutamate
por: Ansah, Twum A., et al.
Publicado: (2011)

Marine biomaterials in biomedical nano/micro-systems
por: Wang, Yanan, et al.
Publicado: (2023)

Progress in Polymeric Nano-Medicines for Theranostic Cancer Treatment
por: Ali, Imran, et al.
Publicado: (2020)

Green Cleaning of 3D-Printed Polymeric Products by Micro-/Nano-Bubbles
por: Gao, Haoxiang, et al.
Publicado: (2023)

The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database
por: Johannes, Catherine B., et al.
Publicado: (2022)

Biodegradable Polymeric Micro/Nano-Structures with Intrinsic Antifouling/Antimicrobial Properties: Relevance in Damaged Skin and Other Biomedical Applications
por: Milazzo, Mario, et al.
Publicado: (2020)

Biocatalytic Synthesis Using Self‐Assembled Polymeric Nano‐ and Microreactors
por: Wang, Yangxin, et al.
Publicado: (2022)

Activated Charge-Reversal Polymeric Nano-System: The Promising Strategy in Drug Delivery for Cancer Therapy
por: Hu, Yichen, et al.
Publicado: (2016)

Polymeric Systems as Antimicrobial or Antifouling Agents
por: Francolini, Iolanda, et al.
Publicado: (2019)

Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model
por: Haghdoost-Yazdi, Hashem, et al.
Publicado: (2017)

Facile Fabrication of Flexible Polymeric Membranes with Micro and Nano Apertures over Large Areas
por: Li, Kebin, et al.
Publicado: (2022)

Nano to micro delivery systems: targeting angiogenesis in brain tumors
por: Gilert, Ariel, et al.
Publicado: (2010)

Nano Polymeric Carrier Fabrication Technologies for Advanced Antitumor Therapy
por: Li, Wei, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l2do0vjd99otbuiqp8b67bs66v